While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a new study counters that belief.
While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a major new study counters that belief.
In the largest study of its kind, researchers with Uppsala University in Uppsala, Sweden, found that breastfeeding might increase the risk of developing hay fever and eczema. Plus, they said, breastfeeding does not have any clear effect on the risk of developing asthma, according to the article published in the Journal of Allergy and Clinical Immunology.
Individuals’ risk of having asthma and allergies depends on their genes, environment and lifestyle factors, wrote Weronica Ek, lead author and researcher at Uppsala University’s Department of Immunology, Genetics and Pathology.
However, studies on breastfeeding have shown inconsistent results. “Many studies have found breastfeeding to have a protective effect against asthma and allergy, while other studies have reported increased risk,” according to an Uppsala University statement.
Meanwhile, the large Uppsala University study examined self-reported data from more than 330,000 middle-aged individuals in the United Kingdom.
They found that increased socioeconomic status lowers the risk of asthma, while it increases the risk of developing hay fever. “These results are in line with the ‘hygiene hypothesis’, which states that growing up in a cleaner environment increases the risk of being diagnosed with allergies due to a lack of early childhood exposure to microorganisms, among other things,” Uppsala University said.
The study also showed that a high body mass index (BMI) increases the risk for asthma, hay fever and eczema. However, the risk for developing all of the conditions decreases in individuals with higher birth weight.
The researchers noted certain limitations to the study, including the fact that it is an observational study, which does not allow for clinical recommendations to be made. “In such studies, there may always be underlying factors that the researchers do not have information about, which are the true causes of the observed effects.”
For example, mothers who have hay fever, asthma or eczema themselves may have been advised to breastfeed or not to breastfeed, which may affect the study’s findings.
“It is well established that breastfeeding has a positive effect on the health of the baby. Even though we do not see a protective effect of breastfeeding on the risk of developing asthma or allergies, these results should not be used to recommend or discourage breastfeeding, since the present study only investigates the effect of breastfeeding on allergies and asthma,” Uppsala University said.
“However, we hope that our study can give a more correct picture of the health benefits of breastfeeding,” Ek added.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More